A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Clinical trial NCT07006506 · RECRUITING
Trial details
- NCT number
- NCT07006506
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-21
- Primary completion
- 2029-05-21
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.